Share This

Call your doctor:  If you think you have been exposed to COVID-19 and develop a fever and symptoms, such as cough or difficulty breathing, call your healthcare provider for medical advice.

Click image to register

Click image to register

LSI COVID-19 Webpage

Latest News

April 24, 2020

Dear Friend,

I hope this email finds you well and safe.

Dr. Robert Katz will present our next COVID-19 and the Lupus Community Web Meeting on Thursday, April 30, 2020.  Register for this event here and email your question for Dr. Katz to mary@lupusil.org.

We rescheduled the Social Security: Change & Confusion webinar featuring attorney Jeff Rabin to July 16, 2020.  You can register here.  

Mr. Rabin will make himself and his presentation available to anyone who can't wait until July 16th.  You can contact him at Jeff@rkblegal.com or call him at 847-652-9114.  If Jeff isn't available you can speak to Susan or Kelli. 

LSI is forwarding our petition to prioritize HCQ for lupus patients first to Governor Pritzker today.  We will keep you posted about our success.  We are leaving the petition up for additional signatures (here). The HCQ issue and our petition was featured on NBC Channel 5 News at 6pm on Wednesday, April 22nd.  You can see the story here.

We know that many of you are still struggling to get HCQ/Plaquenil.  Please email me your stories so we can share those with Governor Pritzker.

The stay at home order is extended through May - which means that we will celebrate Lupus Awareness Month from home. 

Lupus Awareness Month is typically the start of Illinois Lupus Walk season.  We have already postponed the Southern Suburbs Lupus walk from May 2, 2020.  Our Western Suburbs and Chicago Walks have not been postponed and we are looking into new ways to gather the lupus community and bring our lupus voices together in a safe way.  Stay tuned for more information and send your suggestions to info@lupusil.org.

If you have any information that may be helpful to others in the lupus community, please send it to me at mary@lupusil.org.  

Please contact us with your questions and concerns.  We are here to give you reliable, timely information.

Together we'll get through this.  Together we make a difference.

Mary Dollear, President, Lupus Society of Illinois 

Contact Information

Mary Dollear, mary@lupusil.org, (312) 648-6053
Charles Brummell,
charles@lupusil.org, (312) 542-0007
Taurean Jackson,
taurean@lupusil.org, (312) 542-0004

Dr. Robert Katz

COVID-19 & Lupus Community Web Meeting
Presented by Dr. Robert Katz

Thursday, April 30, 2020 | 6:00pm-7:00pm
Registration required for access information

 

Sign! For HCQ to Lupus Patients First

As a result of the anecdotal evidence that chloroquine and hydroxychloroquine benefit in the treatment of COVID-19, lupus patients, whose lives depend on these drugs, are not able to get prescriptions filled.

Lupus patients are on a regimen of medicines to keep life-threatening flares (active disease) at bay.  By upsetting the treatment regimen, they jeopardize their health.

 

COVID-19 & Lupus Community Web Meeting presented by Dr. Meenakshi Jolly

Thanks to Dr. Jolly and everyone who participated in last night's webinar.  The event was recorded and can be viewed here.

Lupus Is Front Page News

The front page of today's Daily Herald includes lupus as front page news: Patients with autoimmune diseases in suburbs struggle to find hydroxychloroquine 

Kim & Corrin Stines 

Lupus and CoVID-19.  An Update
Robert S. Katz, MD and Ben J. Small, MD

Many lupus patients are concerned about how they would handle COVID-19 if they contracted the virus. The answer depends on the patient’s age and the severity of the patient's underlying lupus. 

FULL ARTICLE

 

COVID-19 Individual Peer Support

LSI is expanding our Individual Peer Support to assist during this crisis.

If you are interested in participating in this program or volunteering to talk to others in the lupus community, please complete the form here.

We ask personal information to help match participants and volunteers.  We will not share your information with anyone without getting approval from you.
If you have additional questions, please contact mary@lupusil.org.

COVID-19 & Lupus Web Meeting with Dr. Rosalind Ramsey Goldman

Handout: Wellness
Handout: Exercise

Updates & Additional Questions since the Web Meeting on 4/2/20

Updated information is the change in CDC recommendations to use a mask.  There was more talk about just talking as a way that the virus might spread.

Still the most important things to do are:

  • Social (physical distancing)-6 feet rule;
  • frequent hand washing;
  • also wash high touch areas;
  • stay home as much as possible
  • Face masks prevent you from spreading the virus especially early on when you might be asymptomatic, but face masks do not prevent you from getting it so please do the important health care measures

Please take care of yourselves: refer to the wellness links provided earlier

This is hard to do, but necessary to take care of ourselves

RRG

Questions:

Q: What are some immediate things we can do or add to our diet to give our immune system an extra boost?  (i.e. foods to eat, vitamins to take, fruits to eat.)

A: I am not aware of an immune boosting diet for lupus.  However, we recommend a well balanced diet with fruits and vegetables, whole grains, lean protein, and if you don’t eat dairy or green vegetables and avoid the sun you may want to take a vitamin D supplement.  Avoid processed foods and limit consumption of sugar sweetened beverages and desserts.  I know there are “immune boosting” diets online or recommended by some practitioners.   I think if the recommendations are similar to what I stated at the beginning of this paragraph.

Q: Would plasma from recovered patients be more effective than the vaccine for SLE patients?

A: The efficacy of plasma infusions for COVID-19 is experimental.  This strategy has been tried for other infections and it does not always work.  Therefore, it should be done under supervision either in the hospital or part of a clinical trial.  Once we have scientific evidence for how or if to use this treatment, we will be able to provide more specific guidance.

COVID-19 Global Rheumatology Alliance
This registry is for healthcare providers to enter data about their rheumatology patients with COVID-19 infections. It is hosted on the REDCap survey platform at UCSF.

Quick Links

These sites provide reliable information on COVID-19- - Click the image to be directed to the website.
If you have questions, please contact us at 312-542-0002 or info@lupusil.org

Links to Factual Information

Spanish Language Resources

 

Social Distancing Opportunities

 

COVID-19 & HYDROXYCHLOROQUINE

Cook County Department of Pubic Health's Covid-19 Resources

Us In Lupus has resources for the Lupus Community

GSK's resources for the lupus community

Medicare Coronavirus Information

Medicare expands telehealth for Coronavirus

Get the latest on Coronavirus information from the CDC

Read the Illinois Executive Order on COVID-19

Read Dr. Robert Katz's article on Lupus & COVID-19

Illinois Department of Public Health COVID-19 information

City of Chicago COVID-19 site

ABC Channel 7 Hydroxychloroquine & Lupus

F3 Naperville Concierge Service (FREE)

Associate Board

Steppin' Out for Lupus Dinner Dance

The LSI Associate Board is hosting a fundraiser to benefit the LSI's mission!  It promises to be an eventful night with live music, educational speakers and a silent auction!

Friday, June 5, 2020 | 6:30 PM CDT  to 11:30 PM CDT

Educational Opportunities

Click image to register for this webinar

Illinois Lupus Walks

Click image for more

Click image for more

Click image for more

Lupus Charity Runners

Click image for more

Research Opportunities

Lupus Intervention Fatigue Trial

If you have lupus and suffer from low energy or you feel tired often, you may qualify for the Lupus Intervention Fatigue Trial (LIFT) – a study being done to test two treatment programs to help people with lupus better manage their fatigue.

For more information, download the flyer here

STUDY OF OMEGA-3 REPLACEMENT WITH KRILL OIL IN TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

The study is a 24 week randomized, double-blind controlled multicenter study followed by an open label extension treatment for another 24 weeks. The purpose of this study is to determine whether the correction of the omega-3 deficiency may reduce disease activity in SLE patients.

For more information, download the flyer here.

 

Our Mission

LSI promotes lupus awareness and complements the work of health care professionals by providing personalized resources for the lupus community while supporting research.

312-542-0002 | 800-258-7872 | info@lupusil.org
Follow us!

Unsubscribe